ROBERT C. DAY, LMHC
Mental Health at 35Thst, Seattle, WA
License number
Washington 6420
Category
Mental Health
Type
Mental Health
Address
Address
753 N 35Th St #108, Seattle, WA 98103
Phone
(206) 789-3878
(206) 783-7579
(206) 783-7579
Personal information
See more information about ROBERT C. DAY at radaris.comName
Address
Phone
502 SE 95Th Ave, Vancouver, WA 98664
5233 Kirkwood Pl N, Seattle, WA 98103
14550 Osprey Pl NE, Poulsbo, WA 98370
12035 Cloudy Peak Ln NW, Silverdale, WA 98383
1819 SW Holden St, Seattle, WA 98106
Professional information
See more information about ROBERT C. DAY at trustoria.com
Member At Fred Hutchinson Crc
Member At Fred Hutchinson Crc
Position:
Member at Fred Hutchinson CRC, Chief Medical Officer at Epigenomics AG, member at Fred Hutchinson Cancer Research Center
Location:
Greater Seattle Area
Industry:
Biotechnology
Work:
Fred Hutchinson CRC
-
Member
Epigenomics AG
since 2001
-
Chief Medical Officer
Fred Hutchinson Cancer Research Center
since 1981
-
member
Member At Fred Hutchinson Crc
Member At Fred Hutchinson Crc
Position:
Member at Fred Hutchinson CRC
Location:
Greater Seattle Area
Industry:
Biotechnology
Work:
Fred Hutchinson CRC
-
Member
Independent Biotechnology Professional
Independent Biotechnology Professional
Location:
Greater Seattle Area
Industry:
Biotechnology
Dr. Robert W Day, Seattle WA - MD (Doctor of Medicine)
Dr. Robert W Day, Seattle WA - MD (Doctor of Medicine)
Specialties:
Preventive Medicine
Address:
1872 E Hamlin St, Seattle 98112
(206) 954-9922 (Phone), (206) 328-1719 (Fax)
(206) 954-9922 (Phone), (206) 328-1719 (Fax)
Certifications:
General Preventive Medicine, 1964
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Center Of Chicago / Pritzker School Of Medicine
Usphs Hosp
U Calif Berkeley
Center Of Chicago / Pritzker School Of Medicine
Usphs Hosp
U Calif Berkeley
Nutrient Formulations For Disease Reduction
Nutrient Formulations For Disease Reduction
US Patent:
6646013, Nov 11, 2003
Filed:
Jun 15, 2000
Appl. No.:
09/596036
Inventors:
Anna D. Barker - Portland OR
Robert W. Day - Seattle WA
Anthony J. Dennis - Portland OR
Norman R. Farnsworth - Downers Grove IL
Julie A. Haack - Eugene OR
Joseph M. McCord - Denver CO
John D. Potter - Seattle WA
Robert W. Day - Seattle WA
Anthony J. Dennis - Portland OR
Norman R. Farnsworth - Downers Grove IL
Julie A. Haack - Eugene OR
Joseph M. McCord - Denver CO
John D. Potter - Seattle WA
Assignee:
Nutri-Logics - San Fransisco CA
International Classification:
A61K 3105
US Classification:
514731, 514730, 514728, 514717, 514678, 514725, 514258, 514248, 514458, 514562, 514 25
Abstract:
The instant invention provides a combination of multiple nutrients useful to reduce colon rectal cancer in a mannalian or human subject. Further, the combination provides synergistic ratios of the useful nutrients.
Robert C Day, Seattle WA
Robert C Day, Seattle WA
Specialties:
Psychotherapist
Address:
753 N 35Th St, Seattle, WA 98103
Robert C Day, Seattle WA - LMHC
Robert C Day, Seattle WA - LMHC
Specialties:
Counseling
Address:
753 N 35Th St SUITE 108, Seattle 98103
(206) 789-3878 (Phone)
(206) 789-3878 (Phone)
Languages:
English
Methods And Nucleic Acids For The Analysis Of Colorectal Cell Proliferative Disorders
Methods And Nucleic Acids For The Analysis Of Colorectal Cell Proliferative Disorders
US Patent:
2007018, Aug 9, 2007
Filed:
Jun 23, 2004
Appl. No.:
10/562377
Inventors:
Andrew Sledziewski - Shoreline WA, US
Jeff Thomas - Bellevue WA, US
Robert Day - Seattle WA, US
Lori Tonnes-Priddy - Everett WA, US
Karen Cardon - Renton WA, US
Jeff Thomas - Bellevue WA, US
Robert Day - Seattle WA, US
Lori Tonnes-Priddy - Everett WA, US
Karen Cardon - Renton WA, US
International Classification:
C12Q 1/68, C12M 3/00, C07H 21/04
US Classification:
435006000, 536024300, 435287200
Abstract:
Various aspects of the present invention provide novel diagnostic and prognostic methods for detecting, or for detecting and differentiating between or among colorectal cell proliferative disorders. Preferably, said colorectal cell proliferative disorders are selected from the group consisting of colorectal carcinoma, colon adenomas, and colon polyps. The inventive methods are based on analysis of differential CpG dinucleotide methylation of genomic DNA between or among normal and disease states. Additional embodiments provide nucleic acids and oligomers (including oligonucleotides and peptide nucleic acid (PNA)-oligomers), nucleic acid arrays and kits useful for practicing said methods, and in otherwise detecting, or detecting and differentiating between or among colorectal cell proliferative disorders.
Methods And Nucleic Acids For The Analysis Of Colorectal Cell Proliferative Disorders
Methods And Nucleic Acids For The Analysis Of Colorectal Cell Proliferative Disorders
US Patent:
2004026, Dec 30, 2004
Filed:
Jun 23, 2003
Appl. No.:
10/602494
Inventors:
Andrew Sledziewski - Shoreline WA, US
Jeff Thomas - Bellevue WA, US
Robert Day - Seattle WA, US
Lori Tonnes-Priddy - Everett WA, US
Karen Cardon - Renton WA, US
Jeff Thomas - Bellevue WA, US
Robert Day - Seattle WA, US
Lori Tonnes-Priddy - Everett WA, US
Karen Cardon - Renton WA, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The present invention provides, inter alia, novel diagnostic and prognostic methods for detecting, or for detecting and differentiating between or among colorectal cell proliferative disorders. Preferably, said colorectal cell proliferative disorders are selected from the group consisting of colorectal carcinoma, colon adenomas, and colon polyps. The inventive methods are based on analysis of differential CpG dinucleotide methylation of genomic DNA between or among normal and disease states. Additional embodiments provide nucleic acids and oligomers (including oligonucleotides and peptide nucleic acid (PNA)-oligomers), nucleic acid arrays and kits useful for practicing said methods, and in otherwise detecting, or detecting and differentiating between or among colorectal cell proliferative disorders.